Merck Animal Health has obtained a regulatory approval from USDA for Coccivac-D2, a new generation version of a coccidiosis vaccine that has been previously used successfully in broiler-breeders and commercial layers worldwide. It will replace Coccivac-D and is currently available in 5,000-dose and 1,000-dose vials.
Charlie Broussard, DVM, director of U.S. poultry technical services, said “Coccivac-D2 builds on the field-proven performance and dependability of Coccivac-D, but its spectrum is even more in step with the Eimeria populations found in today’s broiler-breeder and layer operations.”
